The European Hematology Association (EHA) and EMBL’s European Bioinformatics Institute (EMBL-EBI) selected Lymph&Co research fellow Marijn Kramer, currently a postdoc at Stanford University as one of only 20 young scientists to participate in the 2024 Computational Biology Training in Hematology Program.

Computational Biology Training in Hematology provides a unique, year-long training and mentoring experience for early-career researchers who want to specialize in computational and quantitative biology aspects of hematology. The training is a joint effort of the European Hematology Association (EHA) and the European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI).

The top-tier faculty is made up of international leaders in hematology and computational biology whose expertise reflects the topics to be covered in the workshops, including proteomics, genomics, epigenomics, transcriptomics, metabolomics, single cell omics, radiomics, clinical translation, clinical application, machine learning/AI, microbiome and data integration/systems biology.

Cancer Center Amsterdam alumnus, Dr. Marijn Kramer, MD, PhD, is currently a postdoctoral research fellow in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. She is supported by a two-year Paul Fentener van Vlissingen fellowship from Lymph&Co. For her research she studies paired single-cell RNA and T cell receptor sequencing (scRNA/TCR-seq) of patient samples from cellular immunotherapy clinical trials, with the aim to identify biomarkers and/or drivers of CAR T cell activity in patients.

Marijn Kramer

For more information, see the Computations Biology Training Page or contact Marijn Kramer.

This article was created for Cancer Center Amsterdam.

Follow Cancer Center Amsterdam on LinkedIn & Twitter / X.